Isolation of umbilical cord blood stem cells using an automatic functionally closed Sepax system
- Authors: Kotus E.V.1,2
-
Affiliations:
- LLC "Delrus"
- LLC "Innovative medical technologies"
- Issue: Vol 1, No 2 (2006)
- Pages: 76-77
- Section: Research methods
- URL: https://genescells.ru/2313-1829/article/view/239914
- DOI: https://doi.org/10.23868/gc239914
- ID: 239914
Cite item
Open Access
Access granted
Abstract
Umbilical cord blood (PC) is used as a source of hematopoietic stem cells (HSCs) for transplantation in the treatment of a number of hematological and hereditary diseases.
Full Text
About the authors
E. V. Kotus
LLC "Delrus"; LLC "Innovative medical technologies"
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation, Moscow, Ivan Franko str. 4, building 1, office 101; Ivan Franko str. 4, building 15
References
- Tichelli A., Gubelmann A., Schmolck C. et. al. Automated volume reduction of cord blood using the Sepax system. Symposium on PBSC Transplantation, Mulhouse, 1999.
- Zingsem J., Weisbach V., Zimmermann R. et. al. Processing of human umbilical cord blood cells using an automated functionally closed system. American Association of Blood Banks, San Antonio, 2001.
- Castro A., Reboredo N., Diaz A. et. al. Processing of cord blood units using the Sepax (R) (Biosafe) system. ISCT, Dublin, 2004.
- Rubinstein P., Dobrila L., Rosenfield R. et. al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc. Nat. Acad. Sci. USA 1995; 92(22): 10119-22.
- Theunissen K., Boogaerts M., Lauweryns L. et. al. Fully automated and reproducible cord blood processing using the Biosafe Sepax and Coolmix Devices. ASH, San Diego, 2003.
Supplementary files
